Cargando…

The Frequency and Causes of Not-Detected Breast Malignancy in Dynamic Contrast-Enhanced MRI

Breast MR is the most sensitive imaging modality, but there are cases of malignant tumors that are not detected in MR. This study evaluated the frequency and main causes of malignant breast lesions not detected in dynamic contrast-enhanced (DCE) MR. A total of 1707 cases of preoperative breast MR pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Donghun, Kang, Bong Joo, Kim, Sung Hun, Lee, Jeongmin, Park, Ga Eun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689718/ https://www.ncbi.nlm.nih.gov/pubmed/36359419 http://dx.doi.org/10.3390/diagnostics12112575

Ejemplares similares

Pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: Perfusion metrics of dynamic contrast enhanced MRI
por: Lee, Jeongmin, et al.
Publicado: (2018)

The Role of Diffusion-Weighted Imaging Based on Maximum-Intensity Projection in Young Patients with Marked Background Parenchymal Enhancement on Contrast-Enhanced Breast MRI
por: Park, Ga-Eun, et al.
Publicado: (2023)

The Usefulness of Magnetic Resonance Imaging (MRI) for the Detection of Local Recurrence after Mastectomy with Reconstructive Surgery in Breast Cancer Patients
por: Lee, Jeongmin, et al.
Publicado: (2022)

Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer
por: Kim, Yunju, et al.
Publicado: (2018)

Ipsilateral Recurrence of DCIS in Relation to Radiomics Features on Contrast Enhanced Breast MRI
por: Park, Ga Eun, et al.
Publicado: (2022)

Dynamic Contrast-Enhanced MRI Perfusion Parameters as Imaging Biomarkers of Angiogenesis
por: Kim, Sung Hun, et al.
Publicado: (2016)

Evaluation of Computer-Aided Detection (CAD) in Screening Automated Breast Ultrasound Based on Characteristics of CAD Marks and False-Positive Marks
por: Lee, Jeongmin, et al.
Publicado: (2022)

Prognostic Factors of Disease Recurrence in Breast Cancer Using Quantitative and Qualitative Magnetic Resonance Imaging (MRI) Parameters
por: Lee, Jeongmin, et al.
Publicado: (2020)

Radiomics Nomogram: Prediction of 2-Year Disease-Free Survival in Young Age Breast Cancer
por: Lee, Jeongmin, et al.
Publicado: (2022)

Retrospective Review of Missed Cancer Detection and Its Mammography Findings with Artificial-Intelligence-Based, Computer-Aided Diagnosis
por: Park, Ga Eun, et al.
Publicado: (2022)

Extramammary findings on breast MRI: prevalence and imaging characteristics favoring malignancy detection: a retrospective analysis
por: Yang, Soung Moon, et al.
Publicado: (2016)

Usefulness of postoperative surveillance MR for women after breast-conservation therapy: Focusing on MR features of early and late recurrent breast cancer
por: Lee, Jeongmin, et al.
Publicado: (2021)

Breast Dynamic Contrast Enhanced MRI: Fibrocystic Changes Presenting as a Non-mass Enhancement Mimicking Malignancy
por: Milosevic, Zorica C., et al.
Publicado: (2017)

Comparison of Ultrafast Dynamic Contrast-Enhanced (DCE) MRI with Conventional DCE MRI in the Morphological Assessment of Malignant Breast Lesions
por: Ohashi, Akane, et al.
Publicado: (2023)

Significance of Additional Non-Mass Enhancement in Patients with Breast Cancer on Preoperative 3T Dynamic Contrast Enhanced MRI of the Breast
por: Cho, Yun Hee, et al.
Publicado: (2016)

What shear wave elastography parameter best differentiates breast cancer and predicts its histologic aggressiveness?
por: Kim, Hyunjin, et al.
Publicado: (2021)

Ultrafast Dynamic Contrast-enhanced MRI of the Breast: How Is It Used?
por: Kataoka, Masako, et al.
Publicado: (2022)

Takeaways from Pre-Contrast T1 and T2 Breast Magnetic Resonance Imaging in Women with Recently Diagnosed Breast Cancer
por: Han, Seung Hee, et al.
Publicado: (2016)

Ultrafast Dynamic Contrast-Enhanced Breast MRI: Lesion Conspicuity and Size Assessment according to Background Parenchymal Enhancement
por: Kim, Soo-Yeon, et al.
Publicado: (2020)

Enhancement of Ovarian Malignancy on Clinical Contrast Enhanced MRI Studies
por: Pannu, Harpreet K., et al.
Publicado: (2013)

Dual‐input tracer kinetic modeling of dynamic contrast‐enhanced MRI in thoracic malignancies
por: Lee, Sang Ho, et al.
Publicado: (2019)

Value of dynamic contrast enhanced MRI in differential diagnostics of Warthin tumors and parotid malignancies
por: Mikaszewski, Bogusław, et al.
Publicado: (2021)

Prediction of Prognosis in Glioblastoma Using Radiomics Features of Dynamic Contrast-Enhanced MRI
por: Pak, Elena, et al.
Publicado: (2021)

Sigmoid model analysis of breast dynamic contrast‐enhanced MRI: Distinguishing between benign and malignant breast masses and breast cancer subtype prediction
por: Koori, Norikazu, et al.
Publicado: (2022)

Prognostic Prediction Based on Dynamic Contrast-Enhanced MRI and Dynamic Susceptibility Contrast-Enhanced MRI Parameters from Non-Enhancing, T2-High-Signal-Intensity Lesions in Patients with Glioblastoma
por: Jo, Sang Won, et al.
Publicado: (2021)

Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis
por: Xiao, Jennifer, et al.
Publicado: (2021)

Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer
por: Onishi, Natsuko, et al.
Publicado: (2020)

Assessment of Additional MRI-Detected Breast Lesions Using the Quantitative Analysis of Contrast-Enhanced Ultrasound Scans and Its Comparability with Dynamic Contrast-Enhanced MRI Findings of the Breast
Publicado: (2021)

Comparison of Fused Diffusion-Weighted Imaging Using Unenhanced MRI and Abbreviated Post-Contrast-Enhanced MRI in Patients with Breast Cancer
por: Lee, Kyeyoung, et al.
Publicado: (2023)

Contrast-enhanced MRI in evaluating the contralateral breast for synchronous malignancy in patients with invasive lobular cancer
por: Pietrosanu, R, et al.
Publicado: (2012)

Effectivity of combined diffusion-weighted imaging and contrast-enhanced MRI in malignant and benign breast lesions
por: Yadav, Pratiksha, et al.
Publicado: (2018)

Contrast‐enhanced MRI for breast cancer screening
por: Mann, Ritse M., et al.
Publicado: (2019)

The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI
por: Hellgren, Roxanna, et al.
Publicado: (2020)

Residual microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer: comparison of the accuracies of mammography and MRI in predicting pathological residual tumor
por: An, Yeong Yi, et al.
Publicado: (2017)

Quantitative evaluation of contrast agent uptake in standard fat‐suppressed dynamic contrast‐enhanced MRI examinations of the breast
por: Kousi, Evanthia, et al.
Publicado: (2017)

Imaging characteristics of young age breast cancer (YABC) focusing on pathologic correlation and disease recurrence
por: Lee, Jeongmin, et al.
Publicado: (2021)

Differentiation of malignant and benign breast lesions: Added value of the qualitative analysis of breast lesions on diffusion-weighted imaging (DWI) using readout-segmented echo-planar imaging at 3.0 T
por: An, Yeong Yi, et al.
Publicado: (2017)

Discrimination of malignant and benign breast masses using automatic segmentation and features extracted from dynamic contrast-enhanced and diffusion-weighted MRI
por: Jiang, Xinhua, et al.
Publicado: (2018)

Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies
por: Hameeduddin, Ayshea, et al.
Publicado: (2015)

Differentiation of Breast Cancer from Fibroadenoma with Dual-Echo Dynamic Contrast-Enhanced MRI
por: Wang, Shiwei, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nli1pjarbg5vack3u0hgipd9fu